vs 10,564 other HR bills in the 118th — cohort avg 68d
Summary
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
Vote Summary
Yes
432
No
429
Present
1
Not Voting
6
Party Breakdown
Democrats:213 Y210 N
Republicans:218 Y218 N
Independent:1 Y1 N
Bipartisan Score: 9771%
Roll Call
Chamber
Question
Result
Date
Lobbying filings that explicitly cite this bill (42)
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Read the second time. Placed on Senate Legislative Calendar under General Orders. Calendar No. 2.
January 23, 2023
Received in the Senate. Read the first time. Placed on Senate Legislative Calendar under Read the First Time.
January 11, 2023
Motion to reconsider laid on the table Agreed to without objection.
January 11, 2023
On passage Passed by the Yeas and Nays: 220 - 210, 1 Present (Roll no. 29). (text: CR H178)
House
January 11, 2023
Passed/agreed to in House: On passage Passed by the Yeas and Nays: 220 - 210, 1 Present (Roll no. 29). (text: CR H178)
House
January 11, 2023
On motion to recommit Failed by the Yeas and Nays: 212 - 219 (Roll no. 28).
House
January 11, 2023
Considered as unfinished business. (consideration: CR H190-191)
January 11, 2023
POSTPONED PROCEEDINGS - At the conclusion of debate on H.R. 26, the Chair put the question on passage of the motion to recommit and by voice vote, announced that the nays had prevailed. Ms. DeGette demanded the yeas and nays and the Chair postponed further proceedings until a time to be announced.
Cited source text, amounts, lobbyists, and targets
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Client expense: $38,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
Protecting Life on College Campus Act H.R. 435 Protecting Life on College Campus Act S. 16 Life At Conception Act H.R. 431 Heartbeat Protection Act H.R. 175 Equal Rights Amendment H.J. Res 25 & H.J. Res 4 Women's Health Protection Act H.R. 12 & S. 701 No Taxpayer Funding for Abortion and Abortion Insurance Disclosure Act H.R. 7 Defund Planned Parenthood Act 2023 H.R. 371 Parental Notification and Intervention Act S. 1103 Stopping Traffickers and Accomplices Act S. 959 Dismemberment Abortion Ban Act of 2023 H.R. 682 Ensuring Accurate and Complete Abortion Data Reporting Act of 2023 H.R. 632 Born-Alive Abortion Survivors Protection Act H.R. 26 Expressing the sense of Congress condemning the recent attacks on pro-life facilities, groups, and churches. H.Con.Res. 3 Ending Chemical Abortion Act H.R. 5806 Paid Family Leave Chemical abortion H.R. 7024 Child Tax Credit H.R. 5577 FACE Act Repeal Act H.R. 6914 Pregnant Students Rights Act H.R. 6918 Supporting Pregnant Women and Parenting Families Act SAVE Mom's & Babies Act H.R. 427 EPA and abortion pollution The child tax credit The Life Act Preventing Forced Abortions Act Women's Protection in Telehealth Act Women's Right to Know Act Wastewater and clean water issues with chemical abortion pollution Defunding and Debarring Planned Parenthood Reconciliation Child Tax Credit
Client expense: Not reported · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
H.R. 5577, S. 3017 FACE Act Repeal of 2023; S. 2801, H.R. 5492 Veteran Families Health Services Act of 2023; H.R. 8070, S. 4638 Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025; H.R.26, S. 204 Born-Alive Abortion Survivors Protection Act; Shield Laws; S. 4296, H.R. 8801 More Opportunity for Moms to Succeed Act; H.R. 12, S. 701 Womens Health Protection Act of 2023; S. 74, H.R. 4789 Providing for Life Act; H.R. 427, S. 95 Support and Value Expectant Moms and Babies Act; H.R. 7, S. 62; No Taxpayer Funding for Abortion Act and Abortion Insurance Full Disclosure Act of 2023; Emergency Medical Treatment and Active Labor Act; H.R. 8821 HOPE with Fertility Services Act; H.R. 862 Dismemberment Abortion Ban Act of 2023; H.R. 9866 To direct the Secretary of Health and Human Services to conduct a study and submit to Congress a report on contraceptive access at community health centers in health care deserts.; H.R. 632 Ensuring Accurate and Complete Abortion Data Reporting Act; H.R. 7044 Womans Right to Know Act; Budget Reconciliation; Administration Personnel; Presidential Administration Actions; Abortion Ballot Measures; Late-term abortion procedures; H.R. 3054 To amend the Internal Revenue Code of 1986 to allow the child tax credit with respect to stillbirths.; Contraception Issues; S. 712 Connected MOM Act; Support for rural hospitals providing OB services;
Client expense: $310,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
H.R. 5577, S. 3017 FACE Act Repeal of 2023; S. 2801, H.R. 5492 Veteran Families Health Services Act of 2023; H.R. 8070, S. 4638 Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025; S. 4128, H.R. 8029 VA Abortion Transparency Act of 2024; H.R.26, S. 204 Born-Alive Abortion Survivors Protection Act; Shield Laws; H.R. 1126 HOPE Act; H.R. 8362, S. 3622 Unborn Child Support; H.R. 4258, S. 2092 Unborn Child Tax Credit; S. 4296, H.R. 8801 More Opportunity for Moms to Succeed Act; Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2025; Protecting Pain-Capable Unborn Child from Late-Term Abortions; H.R. 12, S. 701 Womens Health Protection Act of 2023; S. 74, H.R. 4789 Providing for Life Act; H.R. 175 Heartbeat Protection Act of 2023; H.R. 427, S. 95 Support and Value Expectant Moms and Babies Act; Chemical abortion drugs; Safe Haven; H.R. 7, S. 62 No Taxpayer Funding for Abortion Act and Abortion Insurance Full Disclosure Act of 2023; Emergency Medical Treatment and Active Labor Act; H.R. 8821 HOPE with Fertility Services Act; H.R. 862 Dismemberment Abortion Ban Act of 2023; S. 5256 A bill to amend the Internal Revenue Code of 1986 to enhance the child tax credit, and for other purposes (Family Security Act); H.R. 9866 To direct the Secretary of Health and Human Services to conduct a study and submit to Congress a report on contraceptive access at community health centers in health care deserts.; H.R. 9747 Continuing Appropriations and Extensions Act, 2025; H.R. 5406 Life.Gov Act; H.R. 6914, S. 2974 Pregnant Students Rights Act; S. 76 Standing with Moms Act; H.R. 6918, S. 3741 Supporting Pregnant and Parenting Women and Families Act; H.R. 632 Ensuring Accurate and Complete Abortion Data Reporting Act; H.R. 7044 Womans Right to Know Act; Budget Reconciliation; Administration Personnel; Presidential Administration Actions; Abortion Ballot Measures; Late-term abortion procedures; H.R. 3054 To amend the Internal Revenue Code of 1986 to allow the child tax credit with respect to stillbirths.; Abortion Funding; Contraception Issues; S. 712 Connected MOM Act; Peace Corps Reauthorization; Support for rural hospitals providing OB services; H.R.10349 Ensuring Justice for Victims of Partial-Birth Abortion Act; Paid Family Leave
Cited source text, amounts, lobbyists, and targets
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
The previous question on the motion to recommit was ordered pursuant to clause 2(b) of rule XIX.
January 11, 2023
Ms. DeGette moved to recommit to the Committee on the Judiciary. (text: CR H187-190)
January 11, 2023
The previous question was ordered pursuant to the rule.
January 11, 2023
DEBATE - The House proceeded with one hour of debate on H.R. 26.
January 11, 2023
Considered under the provisions of rule H. Res. 5. (consideration: CR H178-190)
Government targets: Administration for Children & Families (ACF), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Equal Employment Opportunity Commission (EEOC), Federal Bureau of Investigation (FBI), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)
Cited source text, amounts, lobbyists, and targets
Protecting Life on College Campus Act H.R. 435 Protecting Life on College Campus Act S. 16 Life At Conception Act H.R. 431 Heartbeat Protection Act H.R. 175 Equal Rights Amendment H.J. Res 25 & H.J. Res 4 Women's Health Protection Act H.R. 12 & S. 701 No Taxpayer Funding for Abortion and Abortion Insurance Disclosure Act H.R. 7 Defund Planned Parenthood Act 2023 H.R. 371 Parental Notification and Intervention Act S. 1103 Stopping Traffickers and Accomplices Act S. 959 Dismemberment Abortion Ban Act of 2023 H.R. 682 Ensuring Accurate and Complete Abortion Data Reporting Act of 2023 H.R. 632 Born-Alive Abortion Survivors Protection Act H.R. 26 Expressing the sense of Congress condemning the recent attacks on pro-life facilities, groups, and churches. H.Con.Res. 3 Ending Chemical Abortion Act H.R. 5806 Paid Family Leave Chemical abortion H.R. 7024 Child Tax Credit H.R. 5577 FACE Act Repeal Act H.R. 6914 Pregnant Students Rights Act H.R. 6918 Supporting Pregnant Women and Parenting Families Act SAVE Mom's & Babies Act H.R. 427 EPA and abortion pollution The child tax credit The Life Act Preventing Forced Abortions Act Women's Protection in Telehealth Act Women's Right to Know Act Wastewater and clean water issues with chemical abortion pollution
Client expense: Not reported · Firm income: Not reported
Government targets: Administration for Children & Families (ACF), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Equal Employment Opportunity Commission (EEOC), Federal Bureau of Investigation (FBI), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)
Cited source text, amounts, lobbyists, and targets
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Client expense: $38,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Client expense: $38,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
Protecting Life on College Campus Act H.R. 435 Protecting Life on College Campus Act S. 16 Life At Conception Act H.R. 431 Heartbeat Protection Act H.R. 175 Equal Rights Amendment H.J. Res 25 & H.J. Res 4 Women's Health Protection Act H.R. 12 & S. 701 No Taxpayer Funding for Abortion and Abortion Insurance Disclosure Act H.R. 7 Defund Planned Parenthood Act 2023 H.R. 371 Parental Notification and Intervention Act S. 1103 Stopping Traffickers and Accomplices Act S. 959 Dismemberment Abortion Ban Act of 2023 H.R. 682 Ensuring Accurate and Complete Abortion Data Reporting Act of 2023 H.R. 632 Born-Alive Abortion Survivors Protection Act H.R. 26 Expressing the sense of Congress condemning the recent attacks on pro-life facilities, groups, and churches. H.Con.Res. 3 Ending Chemical Abortion Act H.R. 5806 Paid Family Leave Chemical abortion H.R. 7024 Child Tax Credit H.R. 5577 FACE Act Repeal Act H.R. 6914 Pregnant Students Rights Act H.R. 6918 Supporting Pregnant Women and Parenting Families Act SAVE Mom's & Babies Act H.R. 427 EPA and abortion pollution The child tax credit The Life Act Preventing Forced Abortions Act Women's Protection in Telehealth Act Women's Right to Know Act
Client expense: Not reported · Firm income: Not reported
Government targets: Administration for Children & Families (ACF), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Equal Employment Opportunity Commission (EEOC), Federal Bureau of Investigation (FBI), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)
Cited source text, amounts, lobbyists, and targets
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age and ensure that such child is immediately admitted to a hospital. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486 including support of H.Res.1285. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421), the Womens Protection in Telehealth Act (H.R.8284) and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act (H.R.8459/S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE Act, MOMS Act and others). Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in regards to MOC briefs arguing pro-life position on abortion-related case Kerr v. Planned Parenthood. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regard to the Restore Act (S.4533) to expand and promote research and data collection on reproductive health conditions, to provide training opportunities for medical professionals to learn how to diagnose and treat reproductive health conditions. No position taken. Contacts in support of H.R.8985 (Ogles) to provide for certain conditions on the enforcement of surrogacy contracts related to abortion. Contacts in opposition to the Reproductive Freedom for Women Act (S. 4554) which expresses support for Roe, which essentially held that there were no limits on abortion and states that Roe ought to be built upon. Contacts regarding the American Privacy Rights Act of 2024 (H.R.8818) regarding the ability of states to enforce illegal sales of abortion drugs and the ability of prolife groups to advertise. No position taken this quarter.
Client expense: $50,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421 and others not introduced) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act of 2023 (S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, HOPE act and others). Contacts in regard to legislation (H.Con. Res. 3) to condemn violence directed at pro-life organizations, pregnancy resource centers, and churches related to Supreme Court action on the Dobbs case, including a letter to the U.S. House dated January 10, 2023. Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in in opposition to the proposed Biden rule, Strengthening Temporary Assistance for Needy Families (TANF) as a Safety Net and Work Program, published on October 2, 2023. The Proposed Rule, among other things, targets pregnancy resource centers by threatening to strip them of millions of dollars of funding claiming, without evidence, that pregnancy centers do not meet TANF criteria. Contacts in support of HR 6918, the Supporting Pregnant and Parenting Women and Families Act to prevent implementation of Biden TANF rule including a letter to the U.S. House dated January 18, 2024. Contacts in support of HR 6914, the Pregnant Students Right Act to accommodate pregnant students on college campuses including a letter to the U.S. House dated January 18, 2024. Contacts in support of the Unborn Child Support Act (S.3622/H.R.7052). Contacts in support of MOC briefs arguing pro-life position on abortion-related cases Moyle v. United States, Idaho v. United States, and Alliance for Hippocratic Medicine v. U.S. Food and Drug Administration. Contacts in regards to potential violations of the Partial Birth Abortion Ban Act (and legislation not introduced) and remains discovered at Washington Surgi-Clinic. Contacts in regards to FAA reauthorization and impact on abortion charitable exemptions. No position taken.
Client expense: $60,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
Protecting Life on College Campus Act H.R. 435 Protecting Life on College Campus Act S. 16 Life At Conception Act H.R. 431 Heartbeat Protection Act H.R. 175 Equal Rights Amendment H.J. Res 25 & H.J. Res 4 Women's Health Protection Act H.R. 12 & S. 701 No Taxpayer Funding for Abortion and Abortion Insurance Disclosure Act H.R. 7 Defund Planned Parenthood Act 2023 H.R. 371 Parental Notification and Intervention Act S. 1103 Stopping Traffickers and Accomplices Act S. 959 Dismemberment Abortion Ban Act of 2023 H.R. 682 Ensuring Accurate and Complete Abortion Data Reporting Act of 2023 H.R. 632 Born-Alive Abortion Survivors Protection Act H.R. 26 Expressing the sense of Congress condemning the recent attacks on pro-life facilities, groups, and churches. H.Con.Res. 3 Ending Chemical Abortion Act H.R. 5806 Paid Family Leave Chemical abortion H.R. 7024 Child Tax Credit H.R. 5577 FACE Act Repeal Act H.R. 6914 Pregnant Students Rights Act H.R. 6918 Supporting Pregnant Women and Parenting Families Act SAVE Mom's & Babies Act H.R. 427 EPA and abortion pollution
Client expense: Not reported · Firm income: Not reported
Government targets: Administration for Children & Families (ACF), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Equal Employment Opportunity Commission (EEOC), Federal Bureau of Investigation (FBI), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)
Cited source text, amounts, lobbyists, and targets
Protecting Life on College Campus Act H.R. 435 Protecting Life on College Campus Act S. 16 Life At Conception Act H.R. 431 Heartbeat Protection Act H.R. 175 Equal Rights Amendment H.J. Res 25 & H.J. Res 4 Women's Health Protection Act H.R. 12 & S. 701 Stopping Traffickers and Their Accomplices Act of 2023 S. 959 Parental Notification and Intervention Act S. 1103 Dismemberment Abortion Ban Act of 2023 H.R. 862 Ensuring Accurate and Complete Abortion Data Reporting Act of 2023 H.R 632 Ensuring Accurate and Complete Abortion Data Reporting Act of 2023 S. 15 Born-Alive Abortion Survivors Protection Act H.R. 26 Protecting Life from Chemical Abortions Act H.R. 384 Paid Family Leave Chemical Abortion Ending Chemical Abortion Act H.R. 5806 House Speaker Voting FACE Act Repeal Supportive Services for Pregnant Women Supprting PRCs
Client expense: Not reported · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Environmental Protection Agency (EPA), Equal Employment Opportunity Commission (EEOC), Federal Bureau of Investigation (FBI), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Occupational Safety & Health Administration (OSHA), SENATE, Veterans Affairs, Dept of (VA)
Cited source text, amounts, lobbyists, and targets
Protecting Life on College Campus Act H.R. 435 Protecting Life on College Campus Act S. 16 Life At Conception Act H.R. 431 Heartbeat Protection Act H.R. 175 Equal Rights Amendment H.J. Res 25 & H.J. Res 4 Women's Health Protection Act H.R. 12 & S. 701 Jackson & Gaetz amendments for House NDAA (H.R. 2670) No Taxpayer Funding for Abortion and Abortion Insurance Disclosure Act H.R. 7 Defund Planned Parenthood Act 2023 H.R. 371 Parental Notification and Intervention Act S. 1103 Stopping Traffickers and Accomplices Act S. 959 Dismemberment Abortion Ban Act of 2023 H.R. 682 Ensuring Accurate and Complete Abortion Data Reporting Act of 2023 H.R. 632 Born-Alive Abortion Survivors Protection Act H.R. 26 Expressing the sense of Congress condemning the recent attacks on pro-life facilities, groups, and churches. H.Con.Res. 3 Jackson and Gaetz amendments to House NDAA H.R. 2670 Ending Chemical Abortion Act H.R. 5806 House Speaker Voting Paid Family Leave Chemical abortion H.R. 7024 Child Tax Credit H.R. 5577 FACE Act Repeal Act H.R. 6914 Pregnant Students Rights Act H.R. 6918 Supporting Pregnant Women and Parenting Families Act
Client expense: Not reported · Firm income: Not reported
Government targets: Administration for Children & Families (ACF), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Equal Employment Opportunity Commission (EEOC), Federal Bureau of Investigation (FBI), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)
Cited source text, amounts, lobbyists, and targets
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act of 2023 (S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, and others). Contacts in regard to legislation (H.Con. Res. 3) to condemn violence directed at pro-life organizations, pregnancy resource centers, and churches related to Supreme Court action on the Dobbs case, including a letter to the U.S. House dated January 10, 2023. Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program. Contacts in support of the Pregnant Students Rights Act, which would require institutions of higher education to disseminate information on the rights of, and accommodations and resources for, pregnant students. Contacts in in opposition to the proposed Biden rule, Strengthening Temporary Assistance for Needy Families (TANF) as a Safety Net and Work Program, published on October 2, 2023. The Proposed Rule, among other things, targets pregnancy resource centers by threatening to strip them of millions of dollars of funding claiming, without evidence, that pregnancy centers do not meet TANF criteria.
Client expense: $60,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
Protecting Life on College Campus Act H.R. 435 Protecting Life on College Campus Act S. 16 Life At Conception Act H.R. 431 Heartbeat Protection Act H.R. 175 Equal Rights Amendment H.J. Res 25 & H.J. Res 4 Women's Health Protection Act H.R. 12 & S. 701 Jackson & Gaetz amendments for House NDAA (H.R. 2670) No Taxpayer Funding for Abortion and Abortion Insurance Disclosure Act H.R. 7 Defund Planned Parenthood Act 2023 H.R. 371 Parental Notification and Intervention Act S. 1103 Stopping Traffickers and Accomplices Act S. 959 Dismemberment Abortion Ban Act of 2023 H.R. 682 Ensuring Accurate and Complete Abortion Data Reporting Act of 2023 H.R. 632 Born-Alive Abortion Survivors Protection Act H.R. 26 Expressing the sense of Congress condemning the recent attacks on pro-life facilities, groups, and churches. H.Con.Res. 3 Jackson and Gaetz amendments to House NDAA H.R. 2670 Ending Chemical Abortion Act H.R. 5806 House Speaker Voting Paid Family Leave Chemical abortion
Client expense: Not reported · Firm income: Not reported
Government targets: Administration for Children & Families (ACF), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Equal Employment Opportunity Commission (EEOC), Federal Bureau of Investigation (FBI), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)
Cited source text, amounts, lobbyists, and targets
Protecting Life on College Campus Act H.R. 435 Protecting Life on College Campus Act S. 16 Life At Conception Act H.R. 431 Heartbeat Protection Act H.R. 175 Equal Rights Amendment H.J. Res 25 & H.J. Res 4 Women's Health Protection Act H.R. 12 & S. 701 Stopping Traffickers and Their Accomplices Act of 2023 S. 959 Parental Notification and Intervention Act S. 1103 Dismemberment Abortion Ban Act of 2023 H.R. 862 Ensuring Accurate and Complete Abortion Data Reporting Act of 2023 H.R 632 Ensuring Accurate and Complete Abortion Data Reporting Act of 2023 S. 15 Born-Alive Abortion Survivors Protection Act H.R. 26 Protecting Life from Chemical Abortions Act H.R. 384 Paid Family Leave Chemical Abortion Ending Chemical Abortion Act H.R. 5806 House Speaker Voting
Client expense: Not reported · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Environmental Protection Agency (EPA), Equal Employment Opportunity Commission (EEOC), Federal Bureau of Investigation (FBI), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Occupational Safety & Health Administration (OSHA), SENATE, Veterans Affairs, Dept of (VA)
Cited source text, amounts, lobbyists, and targets
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421) to prohibit abortionists from performing chemical abortions without being physically present. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act of 2023 (S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, and others). Contacts in regard to legislation (H.Con. Res. 3) to condemn violence directed at pro-life organizations, pregnancy resource centers, and churches related to Supreme Court action on the Dobbs case, including a letter to the U.S. House dated January 10, 2023. Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program.
Client expense: $70,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
Protecting Life on College Campus Act H.R. 435 Protecting Life on College Campus Act S. 16 Life At Conception Act H.R. 431 Heartbeat Protection Act H.R. 175 Equal Rights Amendment H.J. Res 25 & H.J. Res 4 Women's Health Protection Act H.R. 12 & S. 701 Stopping Traffickers and Their Accomplices Act of 2023 S. 959 Parental Notification and Intervention Act S. 1103 Dismemberment Abortion Ban Act of 2023 H.R. 862 Ensuring Accurate and Complete Abortion Data Reporting Act of 2023 H.R 632 Ensuring Accurate and Complete Abortion Data Reporting Act of 2023 S. 15 Born-Alive Abortion Survivors Protection Act H.R. 26 Protecting Life from Chemical Abortions Act H.R. 384
Client expense: Not reported · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
Protecting Life on College Campus Act H.R. 435 Protecting Life on College Campus Act S. 16 Life At Conception Act H.R. 431 Heartbeat Protection Act H.R. 175 Equal Rights Amendment H.J. Res 25 & H.J. Res 4 Women's Health Protection Act H.R. 12 & S. 701 Jackson & Gaetz amendments for House NDAA (H.R. 2670) No Taxpayer Funding for Abortion and Abortion Insurance Disclosure Act H.R. 7 Defund Planned Parenthood Act 2023 H.R. 371 Parental Notification and Intervention Act S. 1103 Stopping Traffickers and Accomplices Act S. 959 Dismemberment Abortion Ban Act of 2023 H.R. 682 Ensuring Accurate and Complete Abortion Data Reporting Act of 2023 H.R. 632 Born-Alive Abortion Survivors Protection Act H.R. 26 Expressing the sense of Congress condemning the recent attacks on pro-life facilities, groups, and churches. H.Con.Res. 3 Jackson and Gaetz amendments to House NDAA H.R. 2670
Client expense: Not reported · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
Cited source text, amounts, lobbyists, and targets
Protecting Life on College Campus Act H.R. 435 Protecting Life on College Campus Act S. 16 Life At Conception Act H.R. 431 Heartbeat Protection Act H.R. 175 Equal Rights Amendment H.J. Res 25 & H.J. Res 4 Women's Health Protection Act H.R. 12 & S. 701 Stopping Traffickers and Their Accomplices Act of 2023 S. 959 Parental Notification and Intervention Act S. 1103 Dismemberment Abortion Ban Act of 2023 H.R. 862 Ensuring Accurate and Complete Abortion Data Reporting Act of 2023 H.R 632 Ensuring Accurate and Complete Abortion Data Reporting Act of 2023 S. 15 Born-Alive Abortion Survivors Protection Act H.R. 26 Protecting Life from Chemical Abortions Act H.R. 384
Client expense: Not reported · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
Protecting Life on College Campus Act H.R. 435 Protecting Life on College Campus Act S. 16 Life At Conception Act H.R. 431 Heartbeat Protection Act H.R. 175 Equal Rights Amendment H.J. Res 25 & H.J. Res 4 Women's Health Protection Act H.R. 12 & S. 701 Jackson & Gaetz amendments for House NDAA (H.R. 2670) No Taxpayer Funding for Abortion and Abortion Insurance Disclosure Act H.R. 7 Defund Planned Parenthood Act 2023 H.R. 371 Parental Notification and Intervention Act S. 1103 Stopping Traffickers and Accomplices Act S. 959 Dismemberment Abortion Ban Act of 2023 H.R. 682 Ensuring Accurate and Complete Abortion Data Reporting Act of 2023 H.R. 632 Born-Alive Abortion Survivors Protection Act H.R. 26 Expressing the sense of Congress condemning the recent attacks on pro-life facilities, groups, and churches. H.Con.Res. 3
Client expense: Not reported · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Defense, Dept of (DOD), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
Cited source text, amounts, lobbyists, and targets
Reproductive Rights and Roe v. Wade and Dobbs v. Jackson Womens Health Organization; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions to protect and expand abortion access; Access to reproductive health services, including contraception and abortion, for veterans and servicemembers and dependents; Title X family planning program; Denials of and nondiscrimination in healthcare; Access to contraception and the right to contraception, including the Right to Contraception Act; LGBTQ+ rights; H.R. 26, the so-called Born-Alive Abortion Survivors Protection Act; H.Con.Res. 3, expressing the sense of Congress condemning the recent attacks on pro-life facilities, groups, and churches; H.R. 561 and S. 1031, EACH Act of 2023, regarding access to affordable health insurance plans that cover abortion; H.R. 12 and S. 701, Women's Health Protection Act, regarding access to abortion care; S. 317, Reproductive Freedom for All Act, regarding reproductive health decisions; H.R. 782, Ensuring Womens Right to Reproductive Freedom Act, regarding the right to travel to seek reproductive health care; Funding for costs related to traveling for abortion care; S. 237, Protecting Access to Medication Abortion Act of 2023; H.J.Res.31 and S.J.Res.10, a joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of Veterans Affairs relating to "Reproductive Health Services"; Access to evidence-based medication abortion care; Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction and property damage intended to interfere with reproductive health care services; H.R. 2736 and S. 1231, Stop Antiabortion Disinformation Act, which prohibits deceptive or misleading advertising related to the provision of abortion service; H.R. 459, Secure Access For Essential Reproductive Health Act of 2023, to ensure the privacy of pregnancy termination or loss information under the HIPAA privacy regulations and the HITECH Act; Introduction of a resolution supporting the case of Beatriz, a young woman living in extreme poverty and with Lupus in rural El Salvador who fought for her life against the State to terminate a high-risk pregnancy; H.R. 734, Protection of Women and Girls in Sports Act of 2023, a hateful bill that seeks to exclude transgender, nonbinary, and intersex people from athletics programs in schools; Issues related Alliance for Hippocratic (AHM) v. FDA; H.R. 3420 and S. 1656, My Body, My Data Act of 2023; Paid Family and Medical Leave, including H.R.3481 and S. 1714 the FAMILY Act.
Client expense: $20,000 · Firm income: Not reported
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), SENATE, White House Office
Cited source text, amounts, lobbyists, and targets
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts regarding the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital, including a letter to the U.S. House issued Jan, 10, 2023. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330 and others not introduced) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421) to prohibit abortionists from performing chemical abortions without being physically present. Contacts explaining nonsupport for the Life at Conception Act (H.R. 431) and similar legislation based on lack of clarity and erroneous legal premises. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act of 2023 (S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, and others). Contacts in regard to legislation (H.Con. Res. 3) to condemn violence directed at pro-life organizations, pregnancy resource centers, and churches related to Supreme Court action on the Dobbs case, including a letter to the U.S. House dated January 10, 2023. Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program.
Client expense: $80,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
H.R. 12, S. 701 Womens Health Protection Act of 2023; H.R. 26, S. 204 Born-Alive Abortion Survivors Protection Act; Veterans Affairs Reproductive Health Services Interim Final Rule; S. 74 Providing for Life Act; H.R. 427, S. 95 Support and Value Expectant Moms and Babies Act; H.R. 7, S. 62 No Taxpayer Funding for Abortion Act and Abortion Insurance Full Disclosure Act of 2023; H.R. 398 Protecting Life and Integrity Research Act; H.R. 471, S. 1074 Women's Public Health and Safety Act; S.J.Res. 10, H.J.Res. 31 CRA Resolution against Biden VA Abortion IFR; H.R. 461, S.18 Protect Individuals with Down Syndrome from Selective Abortion Act; H.R. 421 Teleabortion Prevention Act; H.R. 435 Protecting Life on College Campus Act of 2023; S.76, H.R. 517 Standing with Moms Act; S.166 HEALING Mothers and Fathers Act; H.R. 862 Dismemberment Abortion Ban Act; H.R. 632, S. 15 Ensuring Accurate and Complete Abortion Data Reporting Act of 2023; H.R. 983 Second Chance at Life Act; S. 1102 Dignity for Aborted Children Act
Client expense: $300,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
Equal Rights Amendment; Protecting Pain-Capable Unborn Child from Late-Term Abortions; H.R. 12, S. 701 Womens Health Protection Act of 2023; H.R. 26, S. 204 Born-Alive Abortion Survivors Protection Act; H.R. 792, S.78 Child Interstate Abortion Notification Act; Veterans Affairs Reproductive Health Services Interim Final Rule; S. 74 Providing for Life Act; H.R. 175 Heartbeat Protection Act of 2023; H.R. 427, S. 95 Support and Value Expectant Moms and Babies Act; Chemical abortion; Congressional Actions against pro-abortion political violence; H.R. 279 Pharmacist Conscience Protection Act; H.R. 1771 Pregnancy Resource Center Defense Act; H.R. 384 Protecting Life from Chemical Abortions Act; H.R. 1297 To amend title 10, United States Code, to restrict the Secretary of Defense from paying or reimbursing expenses relating to abortion services; H.R. 7, S. 62 No Taxpayer Funding for Abortion Act and Abortion Insurance Full Disclosure Act of 2023; H.R. 398 Protecting Life and Integrity Research Act; H.R. 471, S. 1074 Women's Public Health and Safety Act; H.Con.Res. 3 Expressing the sense of the House of Representatives condemning the recent attacks on pro-life facilities, groups, and churches; H.R. 461, S.18 Protect Individuals with Down Syndrome from Selective Abortion Act; S.959 Stopping Traffickers and Their Accomplices Act; H.R. 437 Reporting Accountability and Abuse Prevention Act; H.R. Resolution 48 Resolution expressing support for the Dobbs decision; H.R. 416 Prohibiting Abortion Industrys Lucrative Loopholes Act; H.R. 383 Nullify FDA REMS change; H.R. 421 Teleabortion Prevention Act; H.R. 435 Protecting Life on College Campus Act of 2023; S.Res. 10, H.Res. 52 Day of Tears Resolution; S.76, H.R. 517 Standing with Moms Act; S. 166 HEALING Mothers and Fathers Act; H.R. 862 Dismemberment Abortion Ban Act; H.R. 632, S. 15 Ensuring Accurate and Complete Abortion Data Reporting Act of 2023; S. 197 American Values Act; H.R. 983 Second Chance at Life Act; H.R. 1470 No Federal Funds for Abortion Travel Expenses Act; H.R. 1126 HOPE Act; S. 1102 Dignity for Aborted Children Act; S. 822 Modification to Department of Defense Travel Authorities for Abortion-Related Expenses Act; Holds on DOD confirmations and promotions.
Client expense: $300,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
Women's Health Protection Act (S. 701/H.R. 12) The Equal Access to Abortion Coverage (EACH) Act (S. 1031/H.R. 561) The Born-Alive Abortion Survivors Protection Act (H.R. 26)
Client expense: $238,667 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
Women's Health Protection Act (S. 701/H.R. 12) The Equal Access to Abortion Coverage (EACH) Act (S. 1031/H.R. 561) The Born-Alive Abortion Survivors Protection Act (H.R. 26) No Taxpayer Funding for Abortion and Abortion Insurance Full Disclosure Act of 2023 (H.R. 7) Protecting Access to Medication Abortion Act (S. 237) Reproductive Freedom For All Act (S. 317) Reaffirming the preemptive authority of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.) and the Public Health Service Act (42 U.S.C. 201 et seq.) (including regulations thereunder) with respect to State laws that inhibit access to or use of any reproductive health product. A concurrent resolution expressing support for the recognition of March 10, 2023, as "Abortion Provider Appreciation Day". (S. Con. Res. 6/H. Con. Res. 23) Abortion Care Awareness Act Expressing the sense of the House of Representatives that policies governing access to medication abortion care in the United States should be equitable and based on science. Stop Anti-Abortion Disinformation (SAD) Act The Black Maternal Health Momnibus Act (not yet introduced)
Client expense: $231,417 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
Reproductive Rights and Roe v. Wade; Federal issues related to state abortion bans and abortion access in the United States; Administrative actions to protect and expand abortion access; Interim final rule on veterans access to reproductive health services; Title X family planning program; Denials of and nondiscrimination in healthcare; Access to contraception and the right to contraception; LGBTQ+ rights; H.R. 26, the so-called Born-Alive Abortion Survivors Protection Act ; H.Con.Res. 3, expressing the sense of Congress condemning the recent attacks on pro-life facilities, groups, and churches; H.R. 561 and S. 1031, the EACH Act of 2023, regarding access to affordable health insurance plans that cover abortion; H.R. 12 and S. 701 the Women's Health Protection Act, regarding access to abortion care; S. 317, the Reproductive Freedom for All Act, regarding reproductive health decisions; H.R. 782, Ensuring Womens Right to Reproductive Freedom Act, regarding the right to travel to seek reproductive health care; H.R. 445, HHS Reproductive and Sexual Health Ombuds Act; Funding for costs related to traveling for abortion care; S. 237, Protecting Access to Medication Abortion Act of 2023; H.J.Res. 31 and S.J.Res.19, a joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of Veterans Affairs relating to "Reproductive Health Services"; Access to evidence-based medication abortion care; Pub. L. 103-259, Freedom of Access to Clinic Entrances (FACE) Act, which prohibits threats of force, obstruction and property damage intended to interfere with reproductive health care services; H.R. XX and S. XX, Stop Anti-Abortion Abortion Disinformation Act, which prohibits deceptive or misleading advertising related to the provision of abortion service; H.R.459 - SAFER Health Act of 2023, to ensure the privacy of pregnancy termination or loss information under the HIPAA privacy regulations and the HITECH Act; Introduction of a resolution supporting the case of Beatriz, a young woman living in extreme poverty and with Lupus in rural El Salvador who fought for her life against the State to terminate a high-risk pregnancy; H.Res. 1209, the Transgender Bill of Rights, recognizing that it is the duty of the Federal Government to develop and implement a Transgender Bill of Rights to protect and codify the rights of transgender and nonbinary people under the law and ensure their access to medical care, shelter, safety, and economic security; Issues related Alliance for Hippocratic (AHM) v. FDA.
Client expense: $10,000 · Firm income: Not reported
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), SENATE, White House Office
Cited source text, amounts, lobbyists, and targets
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Contacts in support of the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 26/ S.204), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital, including a letter to the U.S. House issued Jan, 10, 2023. Contacts regarding legislation to defund certain abortion providers (H.R.128/H.R.371) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding legislation to improve abortion reporting (H.R. 623/S.15 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 175 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.983) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.624/H.R.330) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act (H.R.421) to prohibit abortionists from performing chemical abortions without being physically present. Contacts explaining nonsupport for the Life at Conception Act (H.R. 431) and similar legislation based on lack of clarity and erroneous legal premises. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 78/H.R.371) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Protecting Life and Integrity in Research Act of 2023(H.R. 398) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus (H.R. 435/S.16), which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.62/H.R. 7) to make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 12/S. 701) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts in support of Stopping Traffickers and Their Accomplices Act of 2023 (S.959) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to S.317 (Reproductive Freedom for All Act) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (the Providing for Life Act, Standing with Moms Act, and others). Contacts in regard to legislation (H.Con. Res. 3) to condemn violence directed at pro-life organizations, pregnancy resource centers, and churches related to Supreme Court action on the Dobbs case, including a letter to the U.S. House dated January 10, 2023. Contacts in support of S. 471/H.R. 1074, the Womens Public Health and Safety Act to clarify the authority of states to exclude providers of elective abortion like Planned Parenthood from the states Medicaid program.
Client expense: $80,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
Physician workforce/training (general); Risk Evaluation and Mitigation Strategy (REMS) for Mifepristone (general); Abortion (general); Breast Cancer (general); Coverage of follow up screenings and test for cervical, breast, and lung cancer; Health IT (general); Patient-Physician Relationship (general); Maternal Mortality and Morbidity (general); Graduate Medical Education (general); Teaching Health Center Graduate Medical Education (general); Health professional student loan repayment (General); Womens Preventive Services (general); Administrative Burden (general); Health Insurance Portability and Accountability Act (general); Maternal Mental Health (general); Contraception (general); Inclusion of Pregnant and Lactating Populations in Research (general); Health care for incarcerated women (general); H.R.___/S.___, Preventing Maternal Deaths Act; Care for individuals with disabilities (general); H.Res. 28, Resolution Condemning the Supreme Court's decision to overturn Roe v. Wade and Planned Parenthood v. Casey and committing to advancing reproductive justice and judicial reform; Provider incentive programs related to pregnancy (general); H.R.___/S.___, PREEMIE Act; H.R. 459, Secure Access for Essential Reproductive (SAFER) Health Act; H.R. 1117/S.___, Advancing Safe Medications for Moms and Babies Act; H.R.___/S.___, Protecting Reproductive Freedom Act; Reauthorization of the Pandemics and All Hazards Preparedness Act; Abortion training (general); Remote device monitoring during pregnancy and postpartum; Residential Treatment for Pregnant and Postpartum Women program (SAMHSA); H.R. 12/S. 701, Women's Health Protection Act; H.R. 561/S. 1031, EACH Act of 2023; H.R. 26/S. 204, Born-Alive Abortion Survivors Protection Act; Implementation of P.L. 115-320, Improving Access to Maternity Care Act; H.R. 1475, Hospital Adoption Education Act; Implementation of P.L. 117-328, Consolidated Appropriations Act, including the Pregnant Workers Fairness Act and Into the Light for Maternal Mental Health and Substance Use Disorders Act; H.R.___, Black Maternal Health Momnibus Act; H.R. ___/S.___, CONNECT for Health Act; Implementation of the No Surprises Act contained in P.L. 116-260; H.R.___/S.___, SHINE for Autumn Act; S.Res. 90, A resolution recognizing the significance of endometriosis as an unmet chronic disease for women and designating March 2023 as "Endometriosis Awareness Month.
Client expense: $160,000 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA), White House Office
Cited source text, amounts, lobbyists, and targets
Support for reproductive rights in the following legislation and government actions: H.R.12/S.701, Womens Health Protection Act of 2023 H.R. 561 /S. 1031, Equal Access to Abortion Coverage in Health Insurance Act of 2023 H.R.782, Ensuring Womens Right to Reproductive Freedom Act H.R.1838/S. 1098 Global Health, Empowerment and Rights Act H.R.1723/S. 929, Abortion is Health Care Everywhere Act of 2023 Judicial nominations H. Con. Res. 23/S. Con. Res. 6, Expressing Support for the recognition of March 10, 2023, as Abortion Provider Appreciation Day Supporting reproductive health priorities including funding for the Title X Family Planning Program and the Teen Pregnancy Prevention Program in the FY24 appropriations process. Expressing deep concerns with all the provisions in: S. 317, Reproductive Freedom for All Act Opposing all the provisions in: H.Con.Res.3, Expressing the sense of Congress condemning the recent attacks on pro-life facilities, groups, and churches H.R.26/S. 204, Born-Alive Abortion Survivors Protection Act H.R.7, No Taxpayer Funding for Abortion and Abortion Insurance Full Disclosure Act of 2023 H.J.Res.31/S.J. Res 10, Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of Veterans Affairs relating to "Reproductive Health Services" Opposing legal challenges to: Limit abortion access
Client expense: $140,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
H.R. 26; Born-Alive Abortion Survivors Protection Act, Protecting infants that survive failed abortions H.Con.Res.3; Expressing the sense of Congress condemning the recent attacks on pro-life facilities, groups, and churches, Ensuring proper enforcement of federal laws against targeted pro-life attacks H.R. 7/S. 62; No Taxpayer Funding for Abortion Act, Prohibiting taxpayer funding for abortion H.R. 461/S.18; Protecting Indivduals with Down Syndrome Act, Protecting unborn children with a prenatal diagnosis for Down Syndrome H.R.372; Protecting Life and Taxpayers Act, Prohibting taxpayer funding for organizations that perform abortions H.R. 421; Teleabortion Prevention Act , Requiring chemical aboritons to be performed in the presence of a physician S. 565; Pregnancy Center Secuirty Act, Creating a program to fund security for pregnancy centers H.R. 9197; Stop the Sexualization of Children Act, Ensuring protections for children and parental rights H.R. 485; Stronger Child Abuse Prevention and Treatment Act, Ensuring protections for children and parental rights S.196; Prohibiting Federal Emergencies for Abortion Act , Prohibiting the Federal government from declaring a health emergency regarding abortion H.R. 1927; End Taxpayer Funding of Gender Experimentation Act, Prohibiting the federal funding of procedures that harm children H.R. 2119; Family Violence Prevention and Services Improvement Act, Ensuring protections for victims of family violence H.R. 175; Heartbeat Protection Act, Protecting unborn life from the moment a heartbeat can be detected H.R. 1926; Protecting Children From Experimentation Act, Ensuring protections for vulnerable children
Client expense: $10,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
Hyde Amendment H.R.175 - Heartbeat Protection Act of 2023 H.R. 26/ S. 204- Born-Alive Abortion Survivors Protection Act H.R. 461/ S. 18- Protecting Individuals with Down Syndrome Act H.R. 427/S.95- SAVE Moms and Babies Act H.Con.Res.3- Expressing the sense of Congress condemning the recent attacks on pro-life facilities, groups, and churches
Client expense: Not reported · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
Endorsed H.R.26, the Born-Alive Abortion Survivors Protection Act Endorsed H.Con.Res.3, Expressing the sense of Congress condemning the recent attacks on pro-life facilities, groups, and churches. Endorsed H.R.8839 - Protecting Kids from Candy-Flavored Drugs Act Endorsed potential legislation mirroring H.B.675, Legislature of the State of Idaho, 66th Legislature, Second Regular Session - 2022 Opposed PN93 - Bradley Garcia - The Judiciary Opposed PN90 - JulieRikelman- The Judiciary Opposed PN95 - Nancy G.Abudu- The Judiciary Opposed S.J.Res.4 - Deadline for Ratification of ERA Supported oversight question for the record about Embezzlement of Non‐Profit Organizations/Corporate Fraud investigation with no criminal predicate Endorsed H.R.175 - Heartbeat Protection Act of 2023 Endorsed H.R.461 - Protecting Individuals with Down Syndrome Act Endorsed H.R.8839 (117) - Protecting Kids from Candy-Flavored Drugs Act Endorsed S.823 - END CSAM Act Endorsed H.R.1276 - Protecting Minors from Medical Malpractice Act Endorsed S.751 -Human-AnimalChimeraProhibitionActof 2023 Endorsed congressional letter to FBI regarding Targeting Radical Traditionalist Catholic Ideology Endorsed congressional letter to Attorney General Merrick Garland condemning a memorandum claiming that abortion drugs can be mailed into states that prohibit abortions-directly violating existing law Endorsed S.1103 - Parental Notification and Intervention Act Endorsed S.Res.107 A resolution recognizing the expiration of the Equal Rights Amendment proposed by Congress in March 1972, and observing that Congress has no authority to modify a resolution proposing a constitutional amendment after the amendment has been submitted to the States or after the amendment has expired Endorsed H.R.421 - Teleabortion Prevention Act of 2023 Endorsed H.R.407 - Protect the UNBORN Act Endorsed H.Res.115 - Establishing aWomen's Bill of Rights to reaffirm legal protections afforded towomenunder Federal law Endorsed S.Res.53 A resolution establishing a Women's Bill of Rights to reaffirm legal protections afforded to women under Federal law Endorsed S.959 - Stopping Traffickers and Their Accomplices Act
Client expense: $15,000 · Firm income: Not reported